The treatment of Emphysema & Fibrocystic Breast Disease with vitamins

Emphysema and Fibrocystic Breast Disease: Mitamins custom make quality formulas for the treatment of Emphysema & Fibrocystic Breast Disease with vitamins. A Emphysema & Fibrocystic Breast Disease formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Emphysema and Fibrocystic Breast Disease

  • Amount Per Serving
    % DV
    Vitamin E
    200
    IU
    667%
    Vitamin B6
    50
    mg
    2500%
    Magnesium
    100
    mg
    25%
    Zinc
    10
    mg
    67%
    Flax Seed Powder
    50
    mg
    *
    Astragalus Extract
    50
    mg
    *
  • Amount Per Serving
    % DV
    Ginkgo Extract
    40
    mg
    *
    Grape Seed Extract
    50
    mg
    *
    Green Tea Extract
    50
    mg
    *
    N-Acetyl L-Cysteine
    100
    mg
    *
    L-Glutamine
    50
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Emphysema and Fibrocystic Breast Disease
Monthly Cost: $22.61
Serving Size:4-5
30 Days Money Back Guarantee
100% Satisfaction Guarantee

Emphysema and Fibrocystic Breast Disease Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
Update This Formula
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Medivation Announces Treatment Of First Patient In Phase 2 Trial Of Dimebon(TM) In Huntington's Disease
Medivation, Inc. (Nasdaq: MDVN) today announced treatment of the first patient in its Phase 2 trial of Dimebon(TM) to treat Huntington's disease. Medivation has expanded patient enrollment in the trial by 20 percent -- to 90 patients -- in order to enhance the ability to detect differences between Dimebon and placebo.
Molecular Profiling Can Accurately Predict Survival In Colon Cancer Patients
Researchers in The Netherlands have developed a method of accurately predicting which patients with colon cancer are most likely to have their disease recur after surgery and who would, therefore, be likely to benefit from additional chemotherapy.
This information concerning the support of Emphysema and Fibrocystic Breast Disease treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Mitamins Logo
Home  Multi-Conditions formulas  Asthma, Emphysema & Lung  Emphysema  Emphysema and Fibrocystic Breast Disease
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments